Opportunity Information: Apply for RFA AI 16 002

  • The HHS-NIH11 in the health sector is offering a public funding opportunity titled "Tropical Medicine Research Centers (U19)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855, 93.856,.
  • This funding opportunity was created on Dec 11, 2015 and posted on Dec 11, 2015.
  • Applicants must submit their applications by Jun 03, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
Apply for RFA AI 16 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Tropical Medicine Research Centers (U19) funding opportunity (RFA-AI-16-002) is a National Institutes of Health (NIH) cooperative agreement program administered under HHS/NIH (listed as HHS-NIH11) that aims to support applied, field-relevant research on tropical diseases where they are actually endemic. The core purpose is to fund institutions and organizations that can carry out research focused on the causes of disease, improved diagnosis, prevention strategies, and treatment approaches for tropical diseases in real-world endemic settings. A central theme of the announcement is practicality and relevance to affected regions: the work is expected to be grounded in places where these diseases occur and where the public health need is highest, rather than being primarily laboratory- or clinic-based within the United States.

The scientific scope is intentionally narrow in one important way and broad in another. It is limited to select Neglected Tropical Diseases (NTDs) and the vectors that transmit them, meaning applicants must align their proposals with the eligible NTD targets and vector systems specified by the program. Within that boundary, however, the FOA encourages ambitious and integrated research approaches. Projects can focus on a single pathogen or cover multiple pathogens responsible for NTDs, and the program explicitly welcomes multi-disciplinary research. In practice, this means an application could combine, for example, epidemiology, entomology, clinical research, diagnostics development, implementation science, and intervention evaluation, as long as the work remains centered on the eligible NTDs and their vectors and is conducted in endemic environments.

Because this is a U19 cooperative agreement, it is designed for center-like, coordinated research efforts rather than isolated, single-project grants. Cooperative agreements typically imply substantial involvement from the funding agency in areas such as oversight, coordination, or collaboration expectations, and they often suit programs where NIH anticipates an active partnership to help the research network meet shared objectives. The intent here is to support organized research centers or center-style collaborations capable of sustained work in endemic regions, including the infrastructure and partnerships needed to execute studies responsibly and effectively in-country.

The FOA also draws a firm line around what it will not support: it is not meant for research that can be conducted primarily in U.S. institutions. That language signals that proposals should not simply use endemic countries as sample sources while most work occurs in U.S. laboratories. Instead, the center concept is geared toward research that is embedded in endemic areas, which generally implies local collaborations, on-the-ground study operations, and a focus on problems that are difficult or impossible to address without sustained presence in affected communities.

From an administrative perspective, the opportunity was posted on December 11, 2015 (creation and posted date both listed as December 11, 2015) with an application closing date of June 3, 2016 (both original and current closing dates match). The funding instrument type is a cooperative agreement, and the activity category is health. The CFDA numbers associated with this opportunity are 93.855 and 93.856, which correspond to NIH infectious disease and related research assistance programs. The listed award ceiling is $500,000, indicating the maximum award amount per the announcement record. The eligible applicant category is summarized as "Others (see text field entitled Additional Information on Eligibility for clarification)," which suggests eligibility was broader or more nuanced than a single standard category and would have required applicants to consult the full FOA text for specifics.

Overall, this opportunity is best understood as NIH support for collaborative tropical medicine research centers focused on select NTDs and their vectors, emphasizing multi-pathogen and multi-disciplinary approaches and prioritizing research that is conducted in endemic regions to directly advance understanding, diagnostics, prevention, and treatment where the burden is greatest.

FAQs: Tropical Medicine Research Centers (U19) - RFA-AI-16-002

What is the Tropical Medicine Research Centers (U19) funding opportunity?

It is an NIH cooperative agreement program (U19) titled Tropical Medicine Research Centers, referenced as RFA-AI-16-002. It is administered under HHS/NIH (listed as HHS-NIH11) and is intended to support coordinated, center-style research focused on tropical diseases in the places where they are endemic.

Who is the sponsoring agency and what type of award is this?

The sponsoring agency is the National Institutes of Health (NIH) within HHS. The funding instrument is a cooperative agreement, meaning NIH is expected to have substantial involvement in the program (for example, coordination, oversight, or collaboration expectations) compared with a standard grant.

What is the main goal of this program?

The goal is to fund institutions and organizations that can conduct applied, field-relevant research on tropical diseases in real-world endemic settings. The program emphasizes practical relevance to affected regions and supports work on causes of disease, improved diagnosis, prevention strategies, and treatment approaches.

What kinds of diseases are in scope for this opportunity?

The scientific scope is limited to select Neglected Tropical Diseases (NTDs) and the vectors that transmit them. Proposed projects must align with the eligible NTD targets and vector systems specified by the program.

Does the program support research on disease vectors as well as pathogens?

Yes. The opportunity explicitly includes the vectors that transmit the eligible NTDs, so applications may focus on pathogen biology, vector systems, or integrated work across both, as long as it remains centered on the eligible NTDs and their vectors.

Is this opportunity intended for single-project proposals or coordinated research centers?

It is designed for center-like, coordinated research efforts rather than isolated, single-project grants. The U19 mechanism supports organized research centers or center-style collaborations capable of sustained work in endemic regions.

What does "field-relevant" mean in the context of this FOA?

Based on the announcement description, "field-relevant" means the research is expected to be grounded in endemic locations and designed around practical public health needs in affected regions. The work should be embedded in real-world settings rather than being primarily lab- or clinic-based in the United States.

Does the program require that studies be conducted in endemic regions?

Yes. A central theme is that the work should be conducted where the diseases are endemic and where the public health need is highest. The FOA draws a firm line that it is not meant for research that can be conducted primarily in U.S. institutions.

What types of research activities are encouraged?

The program supports research focused on the causes of disease, improved diagnosis, prevention strategies, and treatment approaches for tropical diseases. It also encourages ambitious and integrated approaches within the boundary of the eligible NTDs and vectors.

Can an application focus on just one pathogen, or must it include multiple pathogens?

Either approach is allowed. Projects can focus on a single pathogen or cover multiple pathogens responsible for NTDs, as long as they align with the eligible NTD targets and vector systems and are conducted in endemic environments.

Are multi-disciplinary approaches allowed or encouraged?

Yes. The FOA explicitly welcomes multi-disciplinary research. Examples mentioned include combinations of epidemiology, entomology, clinical research, diagnostics development, implementation science, and intervention evaluation, provided the work remains centered on the eligible NTDs and their vectors in endemic settings.

What kinds of partnerships or in-country presence are implied by the center concept?

The description indicates the program is geared toward research embedded in endemic areas, which generally implies local collaborations, on-the-ground study operations, and the infrastructure and partnerships needed to execute studies responsibly and effectively in-country.

What types of projects are explicitly not supported?

The FOA is not meant for research that can be conducted primarily in U.S. institutions. It also signals that proposals should not treat endemic countries mainly as sample sources while most work occurs in U.S. laboratories. The emphasis is on sustained, in-region research efforts.

Why does the announcement emphasize that work should not be primarily U.S.-based?

The stated intent is to prioritize research that is practical and directly relevant to affected regions. The FOA frames the highest priority as work that is difficult or impossible to address without a sustained presence in endemic communities and settings.

When was this opportunity posted and what was the application closing date?

The opportunity was posted on December 11, 2015 (with both creation and posted dates listed as December 11, 2015). The application closing date was June 3, 2016 (with both original and current closing dates matching).

What is the activity category for this opportunity?

The activity category is health.

What CFDA numbers are associated with this funding opportunity?

The CFDA numbers listed are 93.855 and 93.856, which are associated with NIH infectious disease and related research assistance programs.

What is the award ceiling listed in the announcement record?

The listed award ceiling is $500,000, which is the maximum award amount shown in the announcement record.

Who is eligible to apply?

The eligible applicant category is summarized as "Others (see text field entitled Additional Information on Eligibility for clarification)." This indicates eligibility was broader or more nuanced than a single standard category and that applicants would need to consult the full FOA text for specifics.

How should applicants interpret the "cooperative agreement" aspect of a U19?

As described, cooperative agreements typically imply substantial involvement from NIH, including potential expectations around oversight, coordination, or collaboration. This mechanism is suited to programs where NIH anticipates an active partnership to help meet shared objectives across a coordinated center effort.

What is the practical takeaway for organizations considering this program?

This opportunity is best understood as NIH support for collaborative tropical medicine research centers focused on select NTDs and their vectors, emphasizing multi-pathogen and multi-disciplinary approaches, and prioritizing research performed in endemic regions to advance understanding, diagnostics, prevention, and treatment where the burden is greatest.

Browse more opportunities from the same agency: HHS-NIH11

Browse more opportunities from the same category: Health

Next opportunity: Mountains to Main Street Urban Outreach Program

Previous opportunity: NIDCD Early Career Research (ECR) Award (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AI 16 002

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AI 16 002) also looked into and applied for these:

Funding Opportunity
Improving the Quality of HIV Service Delivery and Other Priority Public Health Interventions through Training Support for Epidemiology, Monitoring and Evaluation (M&E), Survey and Laboratory Services in Nigeria under the President’s Emergency Plan Apply for CDC RFA GH16 1642

Funding Number: CDC RFA GH16 1642
Agency: HHS-CDC-CGH
Category: Health
Funding Amount: $5,000,000
National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (U24) Apply for PAR 16 047

Funding Number: PAR 16 047
Agency: HHS-NIH11
Category: Health
Funding Amount: $1,000,000
Implementation of One Health and Global Health Security Agenda in Viet Nam Apply for RFI 440 16

Funding Number: RFI 440 16
Agency: USAID-VIE
Category: Health
Funding Amount: $1,400,000
Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Comprehensive Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT2) Apply for RFA RM 15 018

Funding Number: RFA RM 15 018
Agency: HHS-NIH11
Category: Health
Funding Amount: $2,000,000
Emergency Medical Services for Children Targeted Issues Program Apply for HRSA 16 053

Funding Number: HRSA 16 053
Agency: HHS-HRSA
Category: Health
Funding Amount: Case Dependent
Provision of Technical Assistance for Implementation of Comprehensive HIV Care, Treatment, and Support Programs in the United Republic of Tanzania through CDC under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1648

Funding Number: CDC RFA GH16 1648
Agency: HHS-CDC-CGH
Category: Health
Funding Amount: $2,500,000
HIV Vaccine and Biomedical Prevention Research Project Apply for SOL OAA 16 000026

Funding Number: SOL OAA 16 000026
Agency: USAID
Category: Health
Funding Amount: $160,000,000
Metabolomics Data Analysis (R03) Apply for RFA RM 15 021

Funding Number: RFA RM 15 021
Agency: HHS-NIH11
Category: Health
Funding Amount: $100,000
Pre-application: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Comprehensive Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT1) Apply for RFA RM 15 003

Funding Number: RFA RM 15 003
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
U.S.-China Program for Biomedical Collaborative Research (R01) Apply for RFA AI 16 006

Funding Number: RFA AI 16 006
Agency: HHS-NIH11
Category: Health
Funding Amount: $200,000
Adaptation/Optimization of Technology (ADOPTech) to Support Social Functioning (R21) Apply for RFA MH 17 150

Funding Number: RFA MH 17 150
Agency: HHS-NIH11
Category: Health
Funding Amount: $200,000
NHLBI Progenitor Cell Translational Consortium (U01) Apply for RFA HL 16 021

Funding Number: RFA HL 16 021
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
Medical Monitoring Project (MMP) Apply for CDC RFA PS15 150302CONT16

Funding Number: CDC RFA PS15 150302CONT16
Agency: HHS-CDC
Category: Health
Funding Amount: Case Dependent
Demographic Surveillance Study Support in the Republic of Mozambique under President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 11101SUPP

Funding Number: CDC RFA GH11 11101SUPP
Agency: HHS-CDC
Category: Health
Funding Amount: Case Dependent
Provision of comprehensive HIV/AIDS and TB services including prevention, care, support and treatment to prisoners and staff of the prisons service in the Republic of Uganda under the President’s Emergency Plan for AIDS Relief Apply for CDC RFA GH15 159002CONT16

Funding Number: CDC RFA GH15 159002CONT16
Agency: HHS-CDC
Category: Health
Funding Amount: Case Dependent
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01) Apply for PAR 16 021

Funding Number: PAR 16 021
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
Limited Competition: Pediatric Heart Network for the Data Coordinating Center (U24) Apply for RFA HL 17 005

Funding Number: RFA HL 17 005
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
Emergency Medical Services for Children Innovation and Improvement Center Apply for HRSA 16 052

Funding Number: HRSA 16 052
Agency: HHS-HRSA
Category: Health
Funding Amount: Case Dependent
Statewide Family Network Program Apply for SM 16 004

Funding Number: SM 16 004
Agency: HHS-SAMHS
Category: Health
Funding Amount: $95,000
State Offices of Rural Health Grant Program (SORH) Apply for HRSA 16 016

Funding Number: HRSA 16 016
Agency: HHS-HRSA
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AI 16 002", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.